HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 179 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -66.7% | 100 | -66.7% | 0.00% | -100.0% |
| Q2 2016 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | -82.4% | 300 | -70.0% | 0.00% | -80.0% |
| Q4 2015 | $17,000 | +30.8% | 1,000 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $13,000 | -80.9% | 1,000 | -66.7% | 0.00% | -78.9% |
| Q2 2015 | $68,000 | +58.1% | 3,000 | 0.0% | 0.02% | +58.3% |
| Q1 2015 | $43,000 | +48.3% | 3,000 | 0.0% | 0.01% | +100.0% |
| Q4 2014 | $29,000 | +7.4% | 3,000 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $27,000 | -22.9% | 3,000 | -14.3% | 0.01% | -28.6% |
| Q2 2014 | $35,000 | -47.8% | 3,500 | -33.3% | 0.01% | -46.2% |
| Q1 2014 | $67,000 | -15.2% | 5,250 | 0.0% | 0.01% | +18.2% |
| Q4 2013 | $79,000 | +259.1% | 5,250 | +162.5% | 0.01% | +266.7% |
| Q3 2013 | $22,000 | +37.5% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $16,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |